Lipoprotein(a) levels in children and adolescents with diabetes

Revista de Investigacion Clinica

Volumn 49, Issue 6, 1997, Pages 437-443

  Torres Tamayo, Margarite ^a   Zamora González, José ^b   Bravo Ríos, Luz Elena ^a   Cardoso Saldaña, Guillermo ^b   Mendoza Morfín, Fernando ^a   Posadas Romero, Carlos ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Insulin dependent diabetes mellitus; Lipoprotein(a)

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LIPID; LIPOPROTEIN A;

ADOLESCENT; ARTICLE; BLOOD; CHILD; FEMALE; GENETICS; HUMAN; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; SEX DIFFERENCE;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEIN(A); MALE; SEX FACTORS;

EID: 0031265165     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Uttermann G. The mysteries of lipoprotein (a). Science 1989; 246:904-10.
2. Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Uttermann G. Changes of genetic apolipoprotein phenotypes caused liver transplation. Implications for apolipoprotein synthesis. J Clin Invest 1989; 83:137-42.
3. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90:52-60.
4. Uttermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) lipoprotein concentrations in plasma. J Clin Invest 1987; 80:458-85.
5. Gaubatz JW, Ghanem KJ, Guevara J Jr, Nava ML, Patsch W, Morriset JD. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 1990; 31:603.
6. Berg K, Dahlen G, Frick MH. Lp(a) lipoprotein and pre-beta lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6:230-5.
7. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bond G, Qunici GB. Lipoprotein Lp(a) and risk for myocardial infarction. Atherosclerosis 1981; 38:51-61.
8. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a): a risk factor for myocardial infarction. Arteriosclerosis 1988; 8:398-401.
9. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk for myocardial infarction at a young age. Clin Chem 1990;36:20-3.
10. Dahlen GH, Guyton RJ, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoprotein with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
11. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk for myocardial infarction. JAMA 1986; 256:2540-4.
12. Uttermann G. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. Curr Opin Lipidol 1990; 1:404-10.
13. Bruckert E, Davidoff P, Grimaldi A, Truffert J, Giral P, Doumith R, et al. Increased serum levels of lipoprotein (a) in diabetes mellitus and their reduction with glycemic control. JAMA 1990; 263:35-6.
14. Haffner SM, Tuttle KR, Rainwater DL. Decrease of Lp(a) lipoprotein with improved glycemic control in IDDM subjects. Diabetes Care 1991; 14:302-7.
15. Haffner SM, Tuttle KR, Rainwater DL. Lack of change of lipoprotein(a) concentration with improved glycemic control in subjects with type II diabetes. Metabolism 1992; 41;116-20.
16. Arauz C, Lackner C, Ramirez LC. Lipoprotein(a) levels in diabetic patients and its correlation with the metabolic control. Diabetes 1990; 39:64A.
17. Nakata H, Horita K, Eto M. Alteration of lipoprotein(a) concentration with glycemic control in non-insulin dependent diabetic subjects without diabetic complications. Metabolism 1993; 1323-6.
18. Salzer B, Stavljenic A, Jürgens G, Dumic M, Radica A. Polymorphism of apolipoprotein E, lipoprotein(a) and other lipoproteins in children with type I diabetes. Clin Chem 1993; 39:1427-32.
19. Schernthaner G, Kostner GM, Dieplinger H, Prager R, Muhlhouser L. Apolipoproteins (AI, AII, B) Lp(a) and lecithin cholesterol acyl transferase activity in diabetes mellitus. Atherosclerosis 1983; 49:277-93.
20. Levistsky LL, Scanu MA, Gould HS. Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 1991; 14:283-7.
21. Joven J, Vilella E. Serum levels of lipoprotein(a) in patients with well-controlled non-insulin-dependent diabetes mellitus. JAMA 1991; 265:1113-4.
22. Ritter MM, Richter WO, Lyko K, Schwandt P. Lp(a) serum concentrations and metabolic control. Diabetes Care 1992; 15:1441-2.
23. Ramirez L, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P. Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control. Ann Int Med 1992; 117:42-7.
24. Császár A, Dieplinger H, Sandholzer C, Karádi Y, Juhász E, Drexel H. Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 1993; 36:47-51.
25. Dubrey SW, Reaveley A, Leslie DG, O'Donnell, O'Connor M, Seed M. Effect of insulin-dependent diabetes mellitus on lipids and lipoproteins: a study of identical twins. Clin Sci 1993; 84:537-42.
26. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM. Effects of NIDDM on lipoprotein(a) concentration size. Diabetes 1994; 43:942-6.
27. Manual of laboratory operations; lipid research clinics program. Washington: Government Printing Office (DHEW publication No. [NIH]75-628); 1975.
28. De Long DA, De Long ER, Weed PD. A comparison of methods for the estimation of plasma low and very low density lipoprotein cholesterol. JAMA 1986; 286:2372-7.
29. Cazzolato G, Prakasch G, Green S, Kostner GM. The determination of lipoprotein Lp(a) by rate and endpoint nephelometry. Clin Chem Acta 1983; 135:203-8.
30. Kinoch PAM, Lehmann H. Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purpose. Lancet 1977; 2:16.
31. García-Bulnes G, González-Bárcena D, Ibarra A, Pérez-López A, Exaire JE. Un método inmunonefelométrico con rayo láser para la determinación de microalbuminuria. Nefrologia 1994; XIV:341-4.
32. Wang LX, Wilcken LDE, Dudman BNP. Early expression of the apolipoprotein(a) gene: relationship between infants and their parents' serum apolipoprotein(a) levels. Pediatrics 1992, 89:401-6.
33. Posadas RC, Yamamoto KL, Cardoso SG, García G, Zamora GJ, Velazquez PL, et al. Valores de lipoproteina(a) (Lp[a]) en población de la ciudad de México. Memorias XXXII Reunión Soc Mex de Nutr y Endocr, Acapulco, 1992:91.
34. Maeda S, Abe A, Seishima M, Malcino K, Norma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1991; 78:145-50.
35. Kikuchi S, Nakagawa A, Kobayasi K, Li L, Yanagi H, Arinami T, et al. High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) level in the Japanese and Chinese populations. Hum Genet 1993; 92:537-44.
36. Austin MA, Sandholzer Ch, Selby J, Neuman B, Krauss RM, Utermann G. Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet 1992; 51:829-40.
37. Perombelon TFN, Soutar AK, Knight BL Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest 1994; 93:1481-92.
38. Yanagi H, Nakagawa A, Kikichi S, Tanaka T,. Tsuchiya S, Hamaguchi H. Frequent occurrence of familial aggregations of high lipoprotein(a) levels associated with small apolipoprotein(a) isoforms. Hum Genet 1993; 92:545-8.